FIA
BSX icon

FNY Investment Advisers’s Boston Scientific BSX Stock Holding History

FNY Investment Advisers’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,200
Closed -$214K – 979
2025
Q3 		$214K Buy
+2,200
New +$228K 0.07% 262
2021
Q1 		– Sell
-101
Closed -$3K – 801
2020
Q4 		$3K Buy
+101
New +$3.64K ﹤0.01% 675
2019
Q3 		– Sell
-100
Closed -$4K – 901
2019
Q2 		$4K Buy
+100
New +$3.85K ﹤0.01% 723
2018
Q3 		– Sell
-1,000
Closed -$32K – 930
2018
Q2 		$32K Buy
+1,000
New +$30.2K 0.01% 318

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

FNY Investment Advisers's BSX Position: Q4 2025 in Review

FNY Investment Advisers sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 2,200 shares — an estimated $214K sold.

FNY Investment Advisers first reported a position in BSX in Q2 2018 and held it in 4 quarters. The position peaked at $214K in Q3 2025. 1,795 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

  • FNY Investment Advisers reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
  • FNY Investment Advisers sold 2,200 Boston Scientific shares in Q4 2025, an estimated $214K.
  • FNY Investment Advisers first reported a position in Boston Scientific in Q2 2018 and held it in 4 quarters.
  • FNY Investment Advisers's Boston Scientific position peaked at $214K in Q3 2025.
  • 1,795 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.